A study in humans demonstrated that the miR-6825-3p was downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention, showing differential expression significant after false-discovery rate correction [Onuoha et al. DOI:10.1111/cts.13307].